Literature DB >> 20974703

Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury.

James P Luyendyk1, Nigel Mackman, Bradley P Sullivan.   

Abstract

Alpha-naphthylisothiocyanate (ANIT)-induced cholestatic liver injury causes tissue factor (TF)-dependent coagulation in mice, and TF deficiency reduces ANIT-induced liver injury. However, the mechanism whereby TF contributes to hepatotoxicity in this model is not known. Utilizing pharmacological and genetic strategies, we evaluated the contribution of fibrinogen and two distinct receptors for thrombin, protease-activated receptor-1 (PAR-1) and PAR-4, in a model of acute ANIT hepatotoxicity. ANIT administration (60 mg/kg, po) caused a marked induction of the genes encoding the three fibrinogen chains (α, β, and γ) in liver, an increase in plasma fibrinogen, and concurrent deposition of thrombin-cleaved fibrin in liver. Partial depletion of circulating fibrinogen with ancrod did not impact ANIT hepatotoxicity. However, complete fibrin(ogen) deficiency significantly reduced serum alanine aminotransferase activity and hepatocellular necrosis in ANIT-treated mice. ANIT-induced hepatocellular necrosis was similar in PAR-1(-/-) mice compared with PAR-1(+/+) mice. Interestingly, the progression of ANIT-induced hepatocellular necrosis was significantly reduced in PAR-4(-/-) mice and by administration of an inhibitory PAR-4 pepducin (P4Pal-10, 0.5 mg/kg, sc) to wild-type mice 8 h after ANIT treatment. Interestingly, a distinct lesion, parenchymal-type peliosis, was also observed in PAR-4(-/-) mice treated with ANIT and in mice that were given P4Pal-10 prior to ANIT administration. The results suggest that fibrin(ogen), but not PAR-1, contributes to the progression of ANIT hepatotoxicity in mice. Moreover, the data suggest a dual role for PAR-4 in ANIT hepatotoxicity, both mediating an early protection against peliosis and contributing to the progression of hepatocellular necrosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974703      PMCID: PMC3003835          DOI: 10.1093/toxsci/kfq327

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  33 in total

Review 1.  How the protease thrombin talks to cells.

Authors:  S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  Platelet adhesion receptors.

Authors:  M J Williams; X Du; J C Loftus; M H Ginsberg
Journal:  Semin Cell Biol       Date:  1995-10

3.  The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.

Authors:  J M Pearson; A E Schultze; K A Schwartz; M A Scott; J M Davis; R A Roth
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

4.  Mice lacking the thrombin receptor, PAR1, have normal skin wound healing.

Authors:  A J Connolly; D Y Suh; T K Hunt; S R Coughlin
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

5.  Activation of the nuclear receptor FXR induces fibrinogen expression: a new role for bile acid signaling.

Authors:  Andrew M Anisfeld; Heidi R Kast-Woelbern; Hans Lee; Yanqiao Zhang; Florence Y Lee; Peter A Edwards
Journal:  J Lipid Res       Date:  2004-12-16       Impact factor: 5.922

6.  Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats.

Authors:  James P Luyendyk; Jane F Maddox; Christopher D Green; Patricia E Ganey; Robert A Roth
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

7.  A dual thrombin receptor system for platelet activation.

Authors:  M L Kahn; Y W Zheng; W Huang; V Bigornia; D Zeng; S Moff; R V Farese; C Tam; S R Coughlin
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

8.  Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.

Authors:  T T Suh; K Holmbäck; N J Jensen; C C Daugherty; K Small; D I Simon; S Potter; J L Degen
Journal:  Genes Dev       Date:  1995-08-15       Impact factor: 11.361

9.  Platelets and alpha-naphthylisothiocyanate-induced liver injury.

Authors:  M B Bailie; J M Pearson; P B Lappin; A L Killam; R A Roth
Journal:  Toxicol Appl Pharmacol       Date:  1994-12       Impact factor: 4.219

10.  1-naphthylisothiocyanate-induced elevation of biliary glutathione.

Authors:  P A Jean; M B Bailie; R A Roth
Journal:  Biochem Pharmacol       Date:  1995-01-18       Impact factor: 5.858

View more
  10 in total

1.  Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated mice.

Authors:  James P Luyendyk; Kevin C Flanagan; C David Williams; Hartmut Jaeschke; Joyce G Slusser; Nigel Mackman; Glenn H Cantor
Journal:  Toxicol Appl Pharmacol       Date:  2010-11-09       Impact factor: 4.219

2.  Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment.

Authors:  Patricia F Lalor; John Herbert; Roy Bicknell; David H Adams
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-20       Impact factor: 4.052

3.  Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.

Authors:  James P Luyendyk; Karen M Kassel; Katryn Allen; Grace L Guo; Guodong Li; Glenn H Cantor; Bryan L Copple
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury.

Authors:  Bradley P Sullivan; Karen M Kassel; Alice Jone; Matthew J Flick; James P Luyendyk
Journal:  Am J Pathol       Date:  2012-04-13       Impact factor: 4.307

5.  Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice.

Authors:  N Joshi; A K Kopec; K M O'Brien; K L Towery; H Cline-Fedewa; K J Williams; B L Copple; M J Flick; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2014-12-11       Impact factor: 5.824

6.  Von Willebrand factor exerts hepatoprotective effects in acute but not chronic cholestatic liver injury in mice.

Authors:  Lauren G Poole; Anna-Katherine Fournier; Holly M Cline-Fedewa; Anna K Kopec; James P Luyendyk; Dafna J Groeneveld
Journal:  Toxicology       Date:  2021-10-04       Impact factor: 4.571

7.  From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis.

Authors:  Rance Nault; Kelly A Fader; Anna K Kopec; Jack R Harkema; Timothy R Zacharewski; James P Luyendyk
Journal:  Toxicol Sci       Date:  2016-09-09       Impact factor: 4.849

Review 8.  Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?

Authors:  Anna K Kopec; James P Luyendyk
Journal:  Semin Thromb Hemost       Date:  2016-05-04       Impact factor: 4.180

9.  Negative contrast Cerenkov luminescence imaging of blood vessels in a tumor mouse model using [68Ga]gallium chloride.

Authors:  Jeffrey D Steinberg; Anandhkumar Raju; Prashant Chandrasekharan; Chang-Tong Yang; Karen Khoo; Jean-Pierre Abastado; Edward G Robins; David W Townsend
Journal:  EJNMMI Res       Date:  2014-03-08       Impact factor: 3.138

10.  Crosslinked clots formed independently of factor XIII and without fibrinogen-to-fibrin conversion - is this a liver-specific phenomenon?

Authors:  T Lisman
Journal:  J Thromb Haemost       Date:  2018-12-10       Impact factor: 5.824

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.